Warning: fopen(/home/virtual/enm-kes/journal/upload/ip_log/ip_log_2024-12.txt): failed to open stream: Permission denied in /home/virtual/lib/view_data.php on line 100 Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 101 Efficient Dissociation Protocol for Generation of Single Cell Suspension from Human Thyroid Tissue for Single Cell RNA Sequencing
Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Articles

Page Path
HOME > Endocrinol Metab > Volume 37(4); 2022 > Article
Letter
Thyroid Efficient Dissociation Protocol for Generation of Single Cell Suspension from Human Thyroid Tissue for Single Cell RNA Sequencing
Shinae Yi1*orcid, Hyun Jung Kim2*orcid, Bon Seok Koo3, Seong Eun Lee1, Jahyun Choi4, Yea Eun Kang1orcid
Endocrinology and Metabolism 2022;37(4):698-700.
DOI: https://doi.org/10.3803/EnM.2022.1536
Published online: August 29, 2022

1Division of Endocrinology and Metabolism, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea

2Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Korea

3Department of Otolaryngoloy-Head and Neck Surgery, Chungnam National University College of Medicine, Daejeon, Korea

4Department of NGS Business, Macrogen Inc., Seoul, Korea

Corresponding author: Yea Eun Kang. Division of Endocrinology and Metabolism, Department of Internal Medicine, Chungnam National University College of Medicine, 282 Munhwa-ro, Jung-gu, Daejeon 35015, Korea Tel: +82-42-280-7140, Fax: +82-42-280-7140 E-mail: yeeuni220@cnuh.co.kr
*These authors contributed equally to this work.
• Received: July 1, 2022   • Revised: August 5, 2022   • Accepted: August 8, 2022

Copyright © 2022 Korean Endocrine Society

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 2,581 Views
  • 135 Download
  • 1 Web of Science
  • 1 Crossref
  • 1 Scopus
prev next
Single cell RNA sequencing technology is a cutting-edge field that is currently in the spotlight for diverse research applications, such as the identification of rare cell populations or specific markers for specific small cell clusters. In particular, several methods have been suggested for the primary culture system for the ex vivo tissue structure manufactured from the thyroid tissue of a patient [1-3]; however, these are not suitable for single cell RNA sequencing as the manufacturing success rate is very low owing to the low cell viability. Here, we report an efficient dissociation protocol for generation of single cell suspensions from human thyroid tissue for single cell RNA sequencing. The present protocol method comprises the following steps: (1) transferring the separated thyroid tissue to a laboratory while immersed in a low-temperature storage solution; (2) mechanical digestion by chopping of the tissue in the culture dish and transferring it to a transfer container; (3) chemical digestion by reacting with a mixed solution of trypsin and collagenase type 4; and (4) removal of red blood cells and dead cells. The detailed methods are presented below.
1. Collect the biopsy sample and place in a 50 mL conical tube containing 5 mL of Hanks′ Balanced Salt solution (HBSS) (Gibco, Cat# 14025-076, Waltham, MA, USA) on ice and transfer to the laboratory within 15 minutes.
2. Discard the supernatant, add Roswell Park Memorial Institute (RPMI)-1640 (Welgene, Cat# LM011-01, Taipei, Taiwan) Fetal Bovine Serum (FBS) with Red Blood Cell (RBC) lysis buffer (Roche, Cat# 1181438-9001, Basel, Switzerland); then, wash and centrifuge at 4,000 rpm for 5 minutes at 4°C.
 a. Hold the tissue sample with forceps and cut it using a scissor.
 b. Continue cutting so that the tissue is minced into pieces until it can be moved using the bore tip.
3. Quickly transfer the minced biopsy tissue to a 15 mL tube.
4. Add enzyme digestion solution to the tube and mix well.
 a. Prepare the digestion solution by mixing 0.125% trypsin (Sigma Aldrich, Cat# T1426, St. Louis, MO, USA), 1:300 unit/mL collagenase IV (Worthington, Cat# LS004188, Columbus, OH, USA), and 4 mL of RPMI-1640 (FBS free).
 b. After the digestion solution is completely mixed, add it to the minced biopsy tissue.
5. Place the tube containing the biopsy tissue and enzyme digestion solution in a shaking incubator at 37°C and 100 rpm for 60 minutes.
6. Centrifuge at 4,000 rpm for 5 minutes at 4°C.
7. Discard the supernatant and add 1 mL of RPMI-1640 (FBS+; Gibco, Cat# 16000044) to the digested tissue.
8. Perform mechanical digestion using wide bore tips.
 a. Pipet approximately 20 times through a 1 mL wide bore tip so that the tissue clumps in the solution are not visible to the naked eye.
 b. Pipet approximately 50 times at multiple locations in the solution with a 200 μL wide bore tip.
9. Load the sample on a 70 μm pore cell strainer and add 500 μL of RPMI-1640 (FBS+).
Optional: If there is a lot of tissue above the strainer, add an additional 500 μL of RPMI-1640 (FBS+).
10. Centrifuge at 4,000 rpm for 5 minutes at 4°C.
11. Discard the supernatant and mix briefly with 1 mL of RBC lysis buffer (Roche, Cat# 11814389001).
 a. Incubate the tube on ice for 10 minutes with tapping the tube every 2 minutes.
 b. After 10 minutes, centrifuge at 4,000 rpm for 5 minutes at 4°C.
12. Discard the supernatant, add RPMI-1640 (FBS–) with RBC lysis buffer; then, wash and centrifuge at 4,000 rpm for 5 minutes at 4°C.
13. Discard the supernatant and re-suspend in 300 μL of RPMI-1640 (FBS–).
14. Place the sample on a 40 μm pore cell strainer and add 200 μL of RPMI-1640 (FBS+).
15. Remove dead cells
 a. Remove dead cells using the microbeads in the Dead Cell Removal kit (Miltenyi Biotec, Catalogue number: 130-090-101, Gaithersburg, MD, USA).
Optional: If the sample contains cell clumps, strain the sample using 30 μm pre-separation filters to remove clumps before using the Dead Cell Removal kit.
 b. Perform the experiment according to the protocol in the data sheet provided with the cell counter (LUNA-FX7™ Automated Cell Counter, Logos Biosystems, Anyang, USA).
We successfully isolated single cell from normal thyroid tissue, differentiated thyroid cancer tissue, and anaplastic thyroid cancer tissue using the above protocol (Fig. 1). In conclusion, we developed the efficient dissociation protocol for generation of single cell suspensions from human normal thyroid tissue and thyroid tumor tissues for single cell based research.
This study was approved by the Institutional Research and Ethics Committee at Chungnam National University Hospital (CNUH- 2020-11-004-001). Written informed consent was obtained from all patients.

CONFLICTS OF INTEREST

No potential conflict of interest relevant to this article was reported. There was no potential conflict of interest with Macrogen Inc.

Acknowledgements
This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HR20C0025) and the National Research Foundation of Korea (NRF) (grant number: 2021R1C1C1011183) to Yea Eun Kang.
Fig. 1.
Representative images of the cell counter (LUNA-FX7™ Automated Cell Counter, Logos Biosystems). (A) Ninety-three percent viability in the normal thyroid sample from the patient with papillary thyroid microcarinoma after the dissociation protocol (50×). (B) Eighty-six percent viability in the normal thyroid sample from the patient with adenomatous goiter after the dissociation protocol (50×). (C) Ninety-one percent viability in the tumor sample from the patient with papillary thyroid carcinoma after the dissociation protocol (50×). (D) Ninety-three percent viability from the tumor samples from the patient with follicular thyroid carcinoma after the dissociation protocol (50×). (E) Eighty-four percent viability from the tumor samples from the patient with anaplastic thyroid carcinoma after the dissociation protocol (50×). (F) Eighty-six percent viability from the tumor samples from the patient with anaplastic thyroid carcinoma after the dissociation protocol (50×).
enm-2022-1536f1.jpg
  • 1. Wang Y, Li W, Phay JE, Shen R, Pellegata NS, Saji M, et al. Primary cell culture systems for human thyroid studies. Thyroid 2016;26:1131–40.ArticlePubMedPMC
  • 2. Thomas T, Nowka K, Lan L, Derwahl M. Expression of endoderm stem cell markers: evidence for the presence of adult stem cells in human thyroid glands. Thyroid 2006;16:537–44.ArticlePubMed
  • 3. Fierabracci A, Puglisi MA, Giuliani L, Mattarocci S, Gallinella-Muzi M. Identification of an adult stem/progenitor cell-like population in the human thyroid. J Endocrinol 2008;198:471–87.ArticlePubMed

Figure & Data

References

    Citations

    Citations to this article as recorded by  
    • Unraveling the role of the mitochondrial one-carbon pathway in undifferentiated thyroid cancer by multi-omics analyses
      Seong Eun Lee, Seongyeol Park, Shinae Yi, Na Rae Choi, Mi Ae Lim, Jae Won Chang, Ho-Ryun Won, Je Ryong Kim, Hye Mi Ko, Eun-Jae Chung, Young Joo Park, Sun Wook Cho, Hyeong Won Yu, June Young Choi, Min-Kyung Yeo, Boram Yi, Kijong Yi, Joonoh Lim, Jun-Young K
      Nature Communications.2024;[Epub]     CrossRef

    Figure
    • 0
    Efficient Dissociation Protocol for Generation of Single Cell Suspension from Human Thyroid Tissue for Single Cell RNA Sequencing
    Image
    Fig. 1. Representative images of the cell counter (LUNA-FX7™ Automated Cell Counter, Logos Biosystems). (A) Ninety-three percent viability in the normal thyroid sample from the patient with papillary thyroid microcarinoma after the dissociation protocol (50×). (B) Eighty-six percent viability in the normal thyroid sample from the patient with adenomatous goiter after the dissociation protocol (50×). (C) Ninety-one percent viability in the tumor sample from the patient with papillary thyroid carcinoma after the dissociation protocol (50×). (D) Ninety-three percent viability from the tumor samples from the patient with follicular thyroid carcinoma after the dissociation protocol (50×). (E) Eighty-four percent viability from the tumor samples from the patient with anaplastic thyroid carcinoma after the dissociation protocol (50×). (F) Eighty-six percent viability from the tumor samples from the patient with anaplastic thyroid carcinoma after the dissociation protocol (50×).
    Efficient Dissociation Protocol for Generation of Single Cell Suspension from Human Thyroid Tissue for Single Cell RNA Sequencing

    Endocrinol Metab : Endocrinology and Metabolism
    TOP